Media Mentions

July 13, 2023

Findings from a clinical trial have revealed that mothers who received continuous standardised postpartum education and care for one-year experienced significant improvements in their knowledge of self-care and healthy behaviours.

These improvements led to enhanced maternal health outcomes, marking a crucial step forward in addressing postpartum complications.

 

May 28, 2023

Bringing a new life into this world is a miracle, and caring for a new-born is a delicate task that requires undivided attention.

However, for many mothers in Ghana, the postpartum period is a challenging time due to a lack of access to focused care. The postpartum period is a critical time when mothers need to recover from childbirth and adjust to their new role as caregivers.

According to the World Health Organization (WHO), more than 60% of maternal deaths occur during the postpartum period, with 95% of these deaths happening in low and lower-middle-income countries like Ghana. Ghana’s maternal mortality ratio of 308 deaths per 100,000 live births are also higher than the global average.

However, thanks to the Focused Post-Partum Care (Focused-PPC) project, a Randomised Control Trial (RCT) being piloted by Savana Signatures and the University of Notre Dame in the United States, mothers in the Sagnarigu Municipality of the Northern Region now have access to comprehensive postpartum care that meets their clinical care, education, and social support needs. The project is being conducted in four health facilities in the municipality and aims to test and evaluate an integrated postpartum care delivery model that helps fill the gaps that put many mothers at risk of postpartum health issues.

May 26, 2023

Bringing a new life into this world is a miracle, and caring for a new-born is a delicate task that requires undivided attention. However, for many mothers in Ghana, the postpartum period is a challenging time due to a lack of access to focused care. The postpartum period is a critical time when mothers need to recover from childbirth and adjust to their new role as caregivers.

According to the World Health Organization (WHO), more than 60% of maternal deaths occur during the postpartum period, with 95% of these deaths happening in low and lower middle-income countries like Ghana. Ghana’s maternal mortality ratio of 308 deaths per 100,000 live births is also higher than the global average.

However, thanks to the Focused Post-Partum Care (Focused-PPC) project, a Randomised Control Trial (RCT) being piloted by Savana Signatures and the University of Notre Dame in the United States, mothers in the Sagnarigu Municipality of the Northern Region now have access to comprehensive postpartum care that meets their clinical care, education, and social support needs. The project is being conducted in four health facilities in the municipality and aims to test and evaluate an integrated postpartum care delivery model that helps fill the gaps that put many mothers at risk of postpartum health issues.

January 05, 2023

In Sagnarigu in the Northern Region, just as in most parts of Ghana, women who deliver at facilities within the municipality receive little to no education, clinical assessment or peer support tailored to their health needs even though the postpartum period is a high-risk timeframe for maternal deaths and complications. Routine health checks and education offered at health facilities within the municipality are mostly targeted at babies, though new mothers could be at risk of losing their lives due to postpartum health issues.

The situation requires an urgent need for an integrated postpartum care delivery model that is comprehensive and meets the clinical care, education, and support needs of mothers. It is on the back of this need that Focused Post-Partum Care (Focused-PPC), a Randomized Control Trial, was birthed in July 2021 to test and evaluate an innovative postpartum care, education, and support model in the Sagnarigu municipality.

A collaboration between Savana Signatures and the University of Notre Dame, the project is funded in part, with support from the Indiana Clinical and Translational Sciences Institute, and in part by Grant Number ULI TR002529 from the National Institutes of Health. It is also supported with funding from the Eck Institute for Global Health, University of Notre Dame.